NYSE:DHR

Danaher (DHR) Stock Forecast, Price & News

$255.42

-1.96 (-0.76%)

(As of 08/11/2023 08:48 PM ET)

Compare

Today's Range: $254.14
▼
$257.08
50-Day Range: $233.02
▼
$264.87
52-Week Range: $221.22
▼
$303.82

Volume: 1.39 million shs
Average Volume: 2.98 million shs
Market Capitalization: $188.59 billion

P/E Ratio: 29.98
Dividend Yield: 0.42%
Price Target: $293.13

Danaher MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 14.8% Upside
$293.13 Price Target
Short Interest: Healthy
0.75% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: -1.11
Upright™ Environmental Score
News Sentiment: 0.21
Based on 12 Articles This Week
Insider Trading: Selling Shares
$16.94 M Sold Last Quarter
Proj. Earnings Growth: 8.00%
From $8.88 to $9.59 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.67 out of 5 stars

Multi-Sector Conglomerates Sector

3rd out of 22 stocks

Process Control Instruments Industry

4th out of 10 stocks

2.4

Analyst's Opinion

Consensus Rating
Danaher has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 12 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $293.13, Danaher has a forecasted upside of 14.8% from its current price of $255.42.
Amount of Analyst Coverage
Danaher has only been the subject of 3 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.75% of the float of Danaher has been sold short.
Short Interest Ratio / Days to Cover
Danaher has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Danaher has recently increased by 24.26%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Yield
Danaher has a dividend yield of 0.42%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Danaher has been increasing its dividend for 7 years.
Dividend Coverage
The dividend payout ratio of Danaher is 12.68%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Danaher will have a dividend payout ratio of 11.26% next year. This indicates that Danaher will be able to sustain or increase its dividend.

4.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Danaher has received a 57.99% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Plasmid DNA", "Cell analysis systems", "Oligonucleotides", "Medical imaging software", "Colorimetric analysis kits", and "CRISPR gene-editing tools" products. See details.
Environmental Sustainability
The Environmental Impact score for Danaher is -1.11.

2.9

News and Social Media Coverage

News Sentiment
Danaher has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Multi-Sector Conglomerates companies.
News Coverage This Week
MarketBeat has tracked 12 news articles for Danaher this week, compared to 8 articles on an average week.
Search Interest
36 people have searched for DHR on MarketBeat in the last 30 days. This is an increase of 44% compared to the previous 30 days.
MarketBeat Follows
30 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $16,939,454.00 in company stock.
Percentage Held by Insiders
11.10% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
75.68% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Danaher are expected to grow by 8.00% in the coming year, from $8.88 to $9.59 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Danaher is 29.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 125.16.
Price to Earnings Ratio vs. Sector
The P/E ratio of Danaher is 29.98, which means that it is trading at a more expensive P/E ratio than the Multi-Sector Conglomerates sector average P/E ratio of about 5.97.
Price to Earnings Growth Ratio
Danaher has a PEG Ratio of 2.74. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Danaher has a P/B Ratio of 3.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Danaher (NYSE:DHR) Stock

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

DHR Price History

30 days | 90 days | 365 days | Advanced Chart

DHR Stock News Headlines

August 13, 2023 | americanbankingnews.com

Danaher Co. to Post Q3 2023 Earnings of $1.87 Per Share, Zacks Research Forecasts (NYSE:DHR)

August 9, 2023 | finance.yahoo.com

Should You Consider Adding Danaher Corp. (DHR) to Your Portfolio?

August 14, 2023 | Chaikin Analytics (Ad)

Man Behind Wall Street AI Issues Urgent BUY

It flashed bullish on all 10 of the top 10 stocks of 2022 – detecting rare 100% winners during the worst year for stocks since 2008. Here’s its top pick for 2023 (name and ticker).

August 9, 2023 | finance.yahoo.com

Danaher Corporation (DHR) Underperformed in Q2 Due to Slowdown in Bioprocessing Industry

August 4, 2023 | benzinga.com

Calling All Danaher Corporation (DHR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit

August 3, 2023 | stockhouse.com

ROSEN, A Top Ranked Law Firm, Encourages Danaher Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DHR

August 3, 2023 | finance.yahoo.com

15 European Countries with Best Healthcare for Expats

August 2, 2023 | seekingalpha.com

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

August 14, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.

July 29, 2023 | benzinga.com

ROSEN, A TOP RANKED LAW FIRM, Encourages Danaher Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DHR

July 29, 2023 | stockhouse.com

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Danaher Corporation with Losses of $100,000 to Contact the Firm

July 29, 2023 | msn.com

Danaher: I'm Buying This Compounder On Any Weakness

July 28, 2023 | stockhouse.com

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Danaher Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DHR

July 28, 2023 | benzinga.com

Pomerantz Law Firm Announces the Filing of a Class Action Against Danaher Corporation and Certain Officers – DHR

July 28, 2023 | benzinga.com

Danaher Corporation Class Action: DHR Investors Should Contact Robbins LLP if They Suffered Financial Losses in Excess of $100,000

July 27, 2023 | benzinga.com

BetterInvesting™ Magazine Update on Danaher Corp. and Alphabet Inc.

July 27, 2023 | msn.com

Stifel Maintains Danaher (DHR) Hold Recommendation

July 27, 2023 | msn.com

Raymond James Maintains Danaher (DHR) Outperform Recommendation

July 27, 2023 | finance.yahoo.com

Is Danaher (DHR) Modestly Undervalued? An In-depth Analysis

July 25, 2023 | msn.com

Danaher (DHR) Q2 Earnings Beat, Sales Decline 7.7% Y/Y

July 25, 2023 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC) and Danaher (DHR)

July 25, 2023 | markets.businessinsider.com

Citi Reaffirms Their Buy Rating on Danaher (DHR)

July 25, 2023 | cnbc.com

Danaher cut its outlook for 2023, but we're maintaining our rating — here's why

July 25, 2023 | benzinga.com

Danaher Stock Falls After Q2 Earnings - Here's Why

July 25, 2023 | reuters.com

Danaher cuts forecast for annual sales growth as biotech clients face funding crunch

July 25, 2023 | finance.yahoo.com

Danaher (DHR) Q2 Earnings and Revenues Beat Estimates

July 25, 2023 | finance.yahoo.com

Danaher (DHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

See More Headlines

Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

DHR Company Calendar

Ex-Dividend for 7/28 Dividend: 6/29/2023
Last Earnings: 7/25/2023
Dividend Payable: 7/28/2023
Today: 8/13/2023
Next Earnings (Estimated): 10/19/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Process control instruments
Sub-Industry: Industrial Conglomerates
Sector: Multi-Sector Conglomerates
Current Symbol: NYSE:DHR
CUSIP: 23585110
CIK: 313616
Web: www.danaher.com
Phone: (202) 828-0850
Fax: 202-828-0860
Employees: 81,000
Year Founded: 1984

Price Target and Rating

Average Stock Price Forecast: $293.13
High Stock Price Forecast: $340.00
Low Stock Price Forecast: $240.00
Forecasted Upside/Downside: +14.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 16 Analysts

Profitability

EPS (Most Recent Fiscal Year): $8.52
Trailing P/E Ratio: 29.98
Forward P/E Ratio: 28.76
P/E Growth: 2.74
Net Income: $7.21 billion
Net Margins: 20.95%
Pretax Margin: 24.09%
Return on Equity: 15.03%
Return on Assets: 8.75%

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 2.08
Quick Ratio: 1.70

Sales & Book Value

Annual Sales: $31.47 billion
Price / Sales: 5.99
Cash Flow: $14.26 per share
Price / Cash Flow: 17.91
Book Value: $70.05 per share
Price / Book: 3.65

Miscellaneous

Outstanding Shares: 738,350,000
Free Float: 656,395,000
Market Cap: $188.59 billion
Optionable: Optionable
Beta: 0.80

Social Links

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for August 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Steven M. Rales (Age 72)
Co-Founder & Chairman

Mr. Rainer M. Blair (Age 59)
Pres, CEO & Director
Comp: $5.93M

Mr. Mitchell P. Rales (Age 66)
Co-Founder & Director

Mr. Matthew R. McGrew (Age 51)
CFO & Exec. VP
Comp: $2.85M

Dr. Jose-Carlos Gutierrez-Ramos Ph.D. (Age 60)
Sr. VP & Chief Science Officer
Comp: $2.24M

Mr. Joakim Weidemanis (Age 54)
Exec. VP
Comp: $3.13M

Ms. Jennifer L. Honeycutt (Age 53)
Exec. VP
Comp: $2.56M

Mr. Christopher M. Bouda
VP & Chief Accounting Officer

Mr. John Bedford
VP of Investor Relations

Mr. Brian W. Ellis (Age 56)
Sr. VP, Gen. Counsel & Chief Compliance Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

DHR Stock - Frequently Asked Questions

Should I buy or sell Danaher stock right now?: 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last twelve months. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" DHR shares.
View DHR analyst ratings or view top-rated stocks.
What is Danaher's stock price forecast for 2023?: 16 analysts have issued 1 year price targets for Danaher's shares. Their DHR share price forecasts range from $240.00 to $340.00. On average, they expect the company's stock price to reach $293.13 in the next twelve months. This suggests a possible upside of 14.8% from the stock's current price.
View analysts price targets for DHR or view top-rated stocks among Wall Street analysts.
How have DHR shares performed in 2023?: Danaher's stock was trading at $265.42 on January 1st, 2023. Since then, DHR stock has decreased by 3.8% and is now trading at $255.42.
View the best growth stocks for 2023 here.
Are investors shorting Danaher?: Danaher saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 5,070,000 shares, an increase of 24.3% from the July 15th total of 4,080,000 shares. Based on an average daily trading volume, of 3,220,000 shares, the short-interest ratio is currently 1.6 days. Approximately 0.8% of the shares of the stock are short sold.
View Danaher's Short Interest.
When is Danaher's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 19th 2023.
View our DHR earnings forecast.
How were Danaher's earnings last quarter?: Danaher Co. (NYSE:DHR) posted its quarterly earnings results on Tuesday, July, 25th. The conglomerate reported $2.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.01 by $0.04. The conglomerate earned $7.16 billion during the quarter, compared to analysts' expectations of $7.12 billion. Danaher had a net margin of 20.95% and a trailing twelve-month return on equity of 15.03%. The business's quarterly revenue was down 7.7% on a year-over-year basis. During the same period in the prior year, the company earned $2.76 EPS.
Read the conference call transcript.
How often does Danaher pay dividends? What is the dividend yield for Danaher?: Danaher announced a quarterly dividend on Tuesday, May 9th. Stockholders of record on Friday, June 30th will be given a dividend of $0.27 per share on Friday, July 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date is Thursday, June 29th.
Read our dividend analysis for DHR.
What ETFs hold Danaher's stock?: ETFs with the largest weight of Danaher (NYSE:DHR) stock in their portfolio include Invesco Global Water ETF (PIO), Invesco Water Resources ETF (PHO), Alpha Intelligent - Large Cap Growth ETF (AILG), Franklin Genomic Advancements ETF (HELX), Pacer BioThreat Strategy ETF (VIRS), God Bless America ETF (YALL), Putnam BioRevolution ETF (SYNB) and First Trust Water ETF (FIW).
Is Danaher a good dividend stock?: Danaher (NYSE:DHR) pays an annual dividend of $1.08 per share and currently has a dividend yield of 0.42%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 12.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DHR will have a dividend payout ratio of 11.26% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DHR.

What is Rainer M. Blair's approval rating as Danaher's CEO?: 27 employees have rated Danaher Chief Executive Officer Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among the company's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Danaher own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).
What is Danaher's stock symbol?: Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."
Who are Danaher's major shareholders?: Danaher's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (160.50%), BlackRock Inc. (6.81%), Capital International Investors (1.90%), Geode Capital Management LLC (1.82%), Northern Trust Corp (1.08%) and Bank of New York Mellon Corp (1.04%). Insiders that own company stock include Alan G Spoon, Angela S Lalor, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Elias A Zerhouni, Georgeann Couchara, Jennifer Honeycutt, Joakim Weidemanis, Jose-Carlos Gutierrez-Ramos, Linda Filler, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Raymond C Stevens, Robert S Lutz, Teri List and Walter G Lohr.
View institutional ownership trends.
How do I buy shares of Danaher?: Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Danaher's stock price today?: One share of DHR stock can currently be purchased for approximately $255.42.
How much money does Danaher make?: Danaher (NYSE:DHR) has a market capitalization of $188.59 billion and generates $31.47 billion in revenue each year. The conglomerate earns $7.21 billion in net income (profit) each year or $8.52 on an earnings per share basis.
How many employees does Danaher have?: The company employs 81,000 workers across the globe.
Does Danaher have any subsidiaries?: The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, Aldevron, Aldevron L.L.C., American Precision Industries, Applied Biosystems, Applitek NV, Aquatic Infomatics ULC, Aquatic Informatics, Armstrong Tools, BC Distribution BV, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biotechnology Suzhou Co. Ltd., Beckman Coulter Canada LP, Beckman Coulter Commercial Enterprise China Co. Ltd., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd, Beckman Coulter Laboratory Systems Suzhou Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Nederland B.V., Beckman Coulter Nippon GK, Beckman Coulter S.L.U., Beckman Coulter Saudi Arabia Co.Ltd., Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Finance ApS, Biacore International AB, Biosafe S.A., Blue Software LLC, Cepheid, Cepheid AB, Cepheid Canada ULC, Cepheid Europe SAS, Cepheid GmbH, Cepheid HBDC SAS, Cepheid India Private Limited, Cepheid UK Ltd., ChemTreat, ChemTreat Inc., Cispus Hong Kong Holding Limited, Cytiva, Cytiva BioProcess R&D AB, Cytiva Biotechnology Guangzhou Co. Ltd., Cytiva Biotechnology Hang Zhou Co. Ltd., Cytiva Europe GmbH, Cytiva Sweden AB, DCHL Holding BV, DH Denmark Holding ApS, DH Europe Finance II Sarl, DH Europe Finance Sarl, DH Holding Italia SRL, DH Holdings Germany LLC, DH II Luxembourg Sarl, DH Japan Finance Sarl, DH Switzerland Finance Sarl, DH Technologies Development Pte Ltd., DHCY Limited, DHKAB Company AB, DTIL Ireland Holdings Ltd., Danaher China Holdings Ltd., Danaher Finance Company AB, Danaher HK Holdings Ltd., Danaher Medical ApS, Danaher Shanghai Management Co. Ltd., Delta Consolidated Industries, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BV, Esko Graphics BV, Esko Graphics Inc., Esko Software BV, Fluke, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, Gilzoni Ltd., Global Life Sciences Solutions Austria GmbH & Co. KG, Global Life Sciences Solutions Germany GmbH, Global Life Sciences Solutions Korea Ltd., Global Life Sciences Solutions Manufacturing UK Ltd, Global Life Sciences Solutions Operations UK Ltd, Global Life Sciences Solutions Singapore Pte Ltd, Global Life Sciences Solutions USA LLC, Global Life Sciences Technologies Japan KK, Global Life Sciences Technologies Shanghai Co Ltd., Hach Company, Hach Lange GmbH, Hach Lange Sàrl, Hach Water Quality Analytical Instru. Shanghai Co. Ltd., HemoCue AB, HyClone Laboratories LLC, Hybritech Incorporated, Hyclone Life Sciences Solutions India Private Limited, ID Business Solutions Limited, IDBS Group, IRIS International, Imaging Sciences International, Immunotech Sro, Intabio LLC, Integrated DNA Technologies, Integrated DNA Technologies BVBA, Integrated DNA Technologies Inc., Integrated DNA Technologies Pte. Ltd., Intermountain Life Sciences LLC, Iris International Inc., KaVo, KaVo Kerr, Kaltenbach & Voigt, Keithley Instruments, Kipp & Zonen BV, Kollmorgen, Labcyte Inc., Laetus, Launchchange Holding Company, Leica Biosystems Imaging Inc., Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Biosystems Richmond Inc., Leica Instruments Singapore Pte Limited, Leica Microsystems, Leica Microsystems CMS GmbH, Leica Microsystems Cambridge Limited, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems Limited, Leica Microsystems UK Limited, Leica Mikrosysteme GmbH, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS, Life Sciences IP Holdings Corporation, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, MDS Analytical Technologies, Marconi Data Systems, Microtest, Molecular Devices, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Ltd., Nobel Biocare, OTT Hydromet Corp, Pall Aeropower Corporation, Pall Artelis BVBA, Pall Asia Holdings Inc., Pall Austar Lifesciences Limited, Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Canada ULC, Pall China Co. Ltd., Pall Corporation, Pall Europe Limited, Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group Inc., Pall France SAS, Pall GmbH, Pall India Pvt. Ltd., Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BV, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV Irish Branch, Pall Schweiz GmbH, Pall Technology UK Limited, PaloDEX, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., Precision NanoSystems, Precision Nanosystems ULC, Radiometer, Radiometer Medical ApS, Radiometer Turku Oy, Raytek, Reytek Corporation, Sea-Bird Electronics Inc., Sedaru Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Skyland Analytics Inc., Sutron, Swift Biosciences Inc., Sybron Dental Specialties, Tektronix, Thomson Industries, Trojan Technologies, Trojan Technologies Group ULC, VSS Monitoring, Vanrx Pharmasystems Inc., Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies Europe B.V., Videojet Technologies GmbH, Videojet Technologies Inc., Videojet Technologies S Pte.Ltd., Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Ray Optical Systems Inc., X-Rite, X-Rite Europe GmbH, X-Rite Incorporated, XOS, Yukon Hong Kong Holding Limited, and Zhuhai S.E.Z. Videojet Electronics Ltd..
Read More
How can I contact Danaher?: Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The official website for the company is www.danaher.com. The conglomerate can be reached via phone at (202) 828-0850, via email at investor.relations@danaher.com, or via fax at 202-828-0860.

This page (NYSE:DHR) was last updated on 8/14/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial